Italian auditor criticises contract for H1N1 vaccine
BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3546 (Published 05 July 2010) Cite this as: BMJ 2010;341:c3546- Fabio Turone
- 1Milan
The contract between the drug firm Novartis and Italy’s health ministry over the purchase of 24 million doses of the H1N1 flu vaccine Focetria raises “many perplexities,” a report from the Italian Court of Audit (Corte dei Conti) has said.
The court is an autonomous and independent judicial body charged with conducting financial and legislative audits of most public institutions, including the government.
The contract for the swine flu vaccine, worth €187m (£154m; $234m), was signed in August 2009. It was submitted for approval …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.